Double-blind, randomized sham controlled study of deep-TMS add-on treatment for negative symptoms and cognitive deficits in schizophrenia

Rabany, L., Deutsch, L., & Levkovitz, Y. (2014). Journal of Psychopharmacology, 4;28(7):686-690.

The study examined Brainsway® Deep TMS (Transcranial Magnetic Stimulation) as an add-on treatment for negative symptoms and cognitive deficits in schizophrenia. In the study, 30 patients were randomly assigned to receive real or sham Deep TMS (20 sessions), where both patients and operators were not aware of the type of treatment. In the study, negative symptoms  significantly decreased in the group that received real Deep TMS treatment.

Click to view article

Related Resources: